Characterization of marginal zone B cell precursors

Journal of Experimental Medicine

Volumn 202, Issue 9, 2005, Pages 1225-1234

  Srivastava, Bhaskar ^a   Quinn III, William J ^a   Hazard, Kristin ^b   Erikson, Jan ^b   Allman, David ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b WISTAR INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD23 ANTIGEN; COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT COMPONENT C3D RECEPTOR; LIPOPOLYSACCHARIDE; T LYMPHOCYTE ANTIGEN;

ADOPTIVE TRANSFER; ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CELL FUNCTION; CELL MATURATION; CELL PROLIFERATION; ENVIRONMENT; LYMPHOCYTOPENIA; MOUSE; NONHUMAN; ONTOGENY; PRE B LYMPHOCYTE; PRIORITY JOURNAL; SPLEEN CELL; STEADY STATE;

ANIMALS; B-LYMPHOCYTES; BROMODEOXYURIDINE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; KINETICS; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, COMPLEMENT; RECEPTORS, COMPLEMENT 3B; RECEPTORS, COMPLEMENT 3D; RECEPTORS, IGE; SPLEEN; STEM CELLS;

EID: 27744491859     PISSN: 00221007     EISSN: 00221007     Source Type: Journal    
DOI: 10.1084/jem.20051038     Document Type: Article

References (42)

1. Martin, F., and J.F. Kearney. 2002. Marginal-zone B cells. Nat. Rev. Immunol. 2:323-335.
2. Allman, D.M., S.E. Ferguson, and M.P. Cancro. 1992. Peripheral B cell maturation. I. Immature peripheral B cells in adults are heat-stable antigenhi and exhibit unique signaling characteristics. J. Immunol. 149:2533-2540.
3. Allman, D.M., S.E. Ferguson, V.M. Lentz, and M.P. Cancro. 1993. Peripheral B cell maturation. II. Heat-stable antigen(hi) splenic B cells are an immature developmental intermediate in the production of long-lived marrow-derived B cells. J. Immunol. 151:4431-4444.
4. Carsetti, R., G. Kohler, and M.C. Lamers. 1995. Transitional B cells are the target of negative selection in the B cell compartment. J. Exp. Med. 181:2129-2140.
5. Loder, F., B. Mutschler, R.J. Ray, C.J. Paige, P. Sideras, R. Torres, M.C. Lamers, and R. Carsetti. 1999. B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals. J. Exp. Med. 190:75-89.
6. Allman, D., R.C. Lindsley, W. DeMuth, K. Rudd, S.A. Shinton, and R.R. Hardy. 2001. Resolution of three nonproliferative immature splenic B cell subsets reveals multiple selection points during peripheral B cell maturation. J. Immunol. 167:6834-6840.
7. Rolink, A.G., J. Andersson, and F. Melchers. 1998. Characterization of immature B cells by a novel monoclonal antibody, by turnover and by mitogen reactivity. Eur. J. Immunol. 28:3738-3748.
8. Wang, J.H., N. Avitahl, A. Cariappa, C. Friedrich, T. Ikeda, A. Renold, K. Andrikopoulos, L. Liang, S. Pillai, B.A. Morgan, and K. Georgopoulos. 1998. Aiolos regulates B cell activation and maturation to effector state. Immunity. 9:543-553.
9. Cariappa, A., M. Tang, C. Parng, E. Nebelitskiy, M. Carroll, K. Georgopoulos, and S. Pillai. 2001. The follicular versus marginal zone B lymphocyte cell fate decision is regulated by Aiolos, Btk, and CD21. Immunity. 14:603-615.
10. Saito, T., S. Chiba, M. Ichikawa, A. Kunisato, T. Asai, K. Shimizu, T. Yamaguchi, G. Yamamoto, S. Seo, K. Kumano, et al. 2003. Notch2 is preferentially expressed in mature B cells and indispensable for marginal zone B lineage development. Immunity. 18:675-685.
11. Maillard, I., A.P. Weng, A.C. Carpenter, C.G. Rodriguez, H. Sai, L. Xu, D. Allman, J.C. Aster, and W.S. Pear. 2004. Mastermind critically regulates Notch-mediated lymphoid cell fate decisions. Blood. 104:1696-1702.
12. Martin, F., and J.F. Kearney. 2000. Positive selection from newly formed to marginal zone B cells depends on the rate of clonal production, CD19, and btk. Immunity. 12:39-49.
13. Cariappa, A., T.J. Kim, and S. Pillai. 1999. Accelerated emigration of B lymphocytes in the Xid mouse. J. Immunol. 162:4417-4423.
14. Su, T.T., and D.J. Rawlings. 2002. Transitional B lymphocyte subsets operate as distinct checkpoints in murine splenic B cell development. J. Immunol. 168:2101-2110.
15. Petro, J.B., R.M. Gerstein, J. Lowe, R.S. Carter, N. Shinners, and W.N. Khan. 2002. Transitional type 1 and 2 B lymphocyte subsets are differentially responsive to antigen receptor signaling. J. Biol. Chem. 277:48009-48019.
16. Rolink, A., U. Grawunder, T.H. Winkler, H. Karasuyama, and F. Melchers. 1994. IL-2 receptor alpha chain (CD25, TAC) expression defines a crucial stage in pre-B cell development. Int. Immunol. 6:1257-1264.
17. MacLennan, I.C., H. Bazin, D. Chassoux, D. Gray, and J. Lortan. 1985. Comparative analysis of the development of B cells in marginal zones and follicles. Adv. Exp. Med. Biol. 186:139-144.
18. Klinman, N.R., A.R. Pickard, N.H. Sigal, P.J. Gearhart, E.S. Metcalf, and S.K. Pierce. 1976. Assessing B cell diversification by antigen receptor and precursor cell analysis. Ann. Immunol. (Paris). 127:489-502.
19. Dammers, P.M., N.K. de Boer, G.J. Deenen, P. Nieuwenhuis, and F.G. Kroese. 1999. The origin of marginal zone B cells in the rat. Eur. J. Immunol. 29:1522-1531.
20. Vinuesa, C.G., D.M. Sze, M.C. Cook, K.M. Toellner, G.G. Klaus, J. Ball, and I.C. MacLennan. 2003. Recirculating and germinal center B cells differentiate into cells responsive to polysaccharide antigens. Eur. J. Immunol. 33:297-305.
21. Kraal, G. 1992. Cells in the marginal zone of the spleen. Int. Rev. Cytol. 132:31-74.
22. Claassen, E., A. Ott, W.J. Boersma, C. Deen, M.M. Schellekens, C.D. Dijkstra, N. Kors, and N. Van Rooijen. 1989. Marginal zone of the murine spleen in autotransplants: functional and histological observations in the response against a thymus-independent type 2 antigen. Clin. Exp. Immunol. 77:445-451.
23. Samardzic, T., D. Marinkovic, P.J. Nielsen, L. Nitschke, and T. Wirth. 2002. BOB.1/OBF.1 deficiency affects marginal-zone B-cell compartment. Mol. Cell. Biol. 22:8320-8331.
24. high lymphocytes enriched in the splenic marginal zone generate effector cells more rapidly than the bulk of follicular B cells. J. Immunol. 162:7198-7207.
25. Lu, T.T., and J.G. Cyster. 2002. Integrin-mediated long-term B cell retention in the splenic marginal zone. Science. 297:409-412.
26. Roark, J.H., S.H. Park, J. Jayawardena, U. Kavita, M. Shannon, and A. Bendelac. 1998. CD1.1 expression by mouse antigen-presenting cells and marginal zone B cells. J. Immunol. 160:3121-3127.
27. Amano, M., N. Baumgarth, M.D. Dick, L. Brossay, M. Kronenberg, L.A. Herzenberg, and S. Strober. 1998. CD1 expression defines subsets of follicular and marginal zone B cells in the spleen: beta 2-microglobulin-dependent and independent forms. J. Immunol. 161:1710-1717.
28. Won, W.J., and J.F. Kearney. 2002. CD9 is a unique marker for marginal zone B cells, B1 cells, and plasma cells in mice. J. Immunol. 168:5605-5611.
29. Oliver, A.M., F. Martin, G.L. Gartland, R.H. Carter, and J.F. Kearney. 1997. Marginal zone B cells exhibit unique activation, proliferative and immunoglobulin secretory responses. Eur. J. Immunol. 27:2366-2374.
30. Wells, A.D., H. Gudmundsdottir, and L.A. Turka. 1997. Following the fate of individual T cells throughout activation and clonal expansion. Signals from T cell receptor and CD28 differentially regulate the induction and duration of a proliferative response. J. Clin. Invest. 100:3173-3183.
31. Hao, Z., and K. Rajewsky. 2001. Homeostasis of peripheral B cells in the absence of B cell influx from the bone marrow. J. Exp. Med. 194:1151-1164.
32. Mackay, F., S.A. Woodcock, P. Lawton, C. Ambrose, M. Baetscher, P. Schneider, J. Tschopp, and J.L. Browning. 1999. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J. Exp. Med. 190:1697-1710.
33. Schneider, P., H. Takatsuka, A. Wilson, F. Mackay, A. Tardivel, S. Lens, T.G. Cachero, D. Finke, F. Beermann, and J. Tschopp. 2001. Maturation of marginal zone and follicular B cells requires B cell activating factor of the tumor necrosis factor family and is independent of B cell maturation antigen. J. Exp. Med. 194:1691-1697.
34. Carvalho, T.L., T. Mota-Santos, A. Cumano, J. Demengeot, and P. Vieira. 2001. Arrested B lymphopoiesis and persistence of activated B cells in adult interleukin 7(-/)- mice. J. Exp. Med. 194:1141-1150.
35. Yamashita, K., A. Sakamoto, Y. Ohkubo, M. Arima, M. Hatano, Y. Kuroda, and T. Tokuhisa. 2005. c-fos overexpression in splenic B cells augments development of marginal zone B cells. Mol. Immunol. 42:617-625.
36. Dalwadi, H., B. Wei, M. Schrage, T.T. Su, D.J. Rawlings, and J. Braun. 2003. B cell developmental requirement for the G alpha i2 gene. J. Immunol. 170:1707-1715.
37. Makowska, A., N.N. Faizunnessa, P. Anderson, T. Midtvedt, and S. Cardell. 1999. CD1high B cells: a population of mixed origin. Eur. J. Immunol. 29:3285-3294.
38. Khan, W.N., F.W. Alt, R.M. Gerstein, B.A. Malynn, I. Larsson, G. Rathbun, L. Davidson, S. Muller, A.B. Kantor, L.A. Herzenberg, et al. 1995. Defective B cell development and function in Btk-deficient mice. Immunity. 3:283-299.
39. Kimoto, M., K. Nagasawa, and K. Miyake. 2003. Role of TLR4/MD-2 and RP105/MD-1 in innate recognition of lipopolysaccharide. Scand. J. Infect. Dis. 35:568-572.
40. Anzelon, A.N., H. Wu, and R.C. Rickert. 2003. Pten inactivation alters peripheral B lymphocyte fate and reconstitutes CD19 function. Nat. Immunol. 4:287-294.
41. Hozumi, K., N. Negishi, D. Suzuki, N. Abe, Y. Sotomaru, N. Tamaoki, C. Mailhos, D. Ish-Horowicz, S. Habu, and M.J. Owen. 2004. Delta-like 1 is necessary for the generation of marginal zone B cells but not T cells in vivo. Nat. Immunol. 5:638-644.
42. Pillai, S., A. Cariappa, and S.T. Moran. 2005. Marginal zone B cells. Annu. Rev. Immunol. 23:161-196.